Nexgel(NXGL.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Nexgel
NXGL.US
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions.
306.26 B
NXGL.USMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
Health Care SuppliesIndustry
Industry Ranking34/45
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-69.87%E
    • Profit Margin-28.54%E
    • Gross Margin40.04%B
  • Growth ScoreC
    • Revenue YoY10.14%B
    • Net Profit YoY-2.39%C
    • Total Assets YoY11.12%B
    • Net Assets YoY-19.50%E
  • Cash ScoreC
    • Cash Flow Margin44.01%C
    • OCF YoY10.14%B
  • Operating ScoreA
    • Turnover1.02A
  • Debt ScoreD
    • Gearing Ratio61.36%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    NEXGEL shares are trading higher after the company announced data from randomized, 30-patient, single-center Institutional Review Board clinical study.

    benzinga_article·
    US
    NXGL
    +20.14%
    US
    IBB
    +0.10%
    US
    PBE
    +0.11%
    benzinga_article·
    US
    NXGL
    +20.14%
    US
    IBB
    +0.10%
    US
    PBE
    +0.11%

    NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise

    TradingView·
    US
    NXGL
    +20.14%
    US
    XBI
    -0.69%
    US
    FBT
    +0.54%
    TradingView·
    US
    NXGL
    +20.14%
    US
    XBI
    -0.69%
    US
    FBT
    +0.54%

    NexGel Q1 2026 Earnings Call Transcript

    benzinga_article·
    US
    NXGL
    +20.14%
    US
    SBIO
    -1.24%
    US
    IBB
    +0.10%
    benzinga_article·
    US
    NXGL
    +20.14%
    US
    SBIO
    -1.24%
    US
    IBB
    +0.10%

    Nexgel | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 2.65 M

    Earnings Watch·
    US
    NXGL
    +20.14%
    Earnings Watch·
    US
    NXGL
    +20.14%

    NEXGEL To Report First Quarter 2026 Financial Results on May 15th | NXGL Stock News

    StockTitan·
    US
    NXGL
    +20.14%
    US
    SBIO
    -1.24%
    US
    LABU
    -2.35%
    StockTitan·
    US
    NXGL
    +20.14%
    US
    SBIO
    -1.24%
    US
    LABU
    -2.35%
    © 2026 Longbridge｜Disclaimer